Pemivibart every three months. For those who cannot receive the COVID-19 vaccine.
adintrevimab
Posted inClinical Trials, COVID-19, Infections
Adintrevimab: Cure for All Mutant Variants of SARS-CoV-2
Adagio Therapeutics’ monoclonal antibody will help fight all variants of the coronavirus.